Facteur 23 de croissance du fibroblaste (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Facteur 23 de croissance du fibroblaste" in French language version.

refsWebsite

Global rank French rank

16nih.gov

4^th place

12^th place

3ahajournals.org

3,608^th place

659^th place

2ensembl.org

1,626^th place

2,018^th place

2asnjournals.org

low place

8,208^th place

2nejm.org

2,374^th place

298^th place

2physiology.org

5,293^rd place

3,227^th place

1wiley.com

222^nd place

129^th place

1nature.com

234^th place

147^th place

1jci.org

low place

3,702^nd place

1sciencedirect.com

149^th place

80^th place

1jamanetwork.com

2,650^th place

689^th place

1annals.org

low place

1,894^th place

1oxfordjournals.org

1,389^th place

508^th place

ahajournals.org

circ.ahajournals.org

(en) Gutierrez OM, Januzzi JL, Isakova T. et al. « Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease » Circulation 2009;119:2545-52. PMID 19414634
Mathew JS, Sachs MC, Patton KK et al. Fibroblast growth factor-23 and incident atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis (MESA) and the Cardiovascular Health Study (CHS), Circulation, 2014;130:298–307

jaha.ahajournals.org

(en) Agarwal I, Ide N, Ix JH. et al. « Fibroblast Growth Factor–23 and cardiac structure and function » J Am Heart Assoc. 2014;3:e000584. PMID 24525546

annals.org

(en) Parker BD, Schurgers LJ, Brandenburg VM. et al. « The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study » Ann Intern Med. 2010;152:640-8. PMID 20479029

asnjournals.org

jasn.asnjournals.org

(en) Imel EA, Econs MJ. « Fibroblast growth factor 23: roles in health and disease » J Am Soc Nephrol. 2005;16:2565–75. PMID 16033853
(en) Liu S, Quarles LD. « How fibroblast growth factor 23 works » J Am Soc Nephrol. 2007;18:1637–47. PMID 17494882

ensembl.org

May2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000118972 - Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000000182 - Ensembl, May 2017

jamanetwork.com

jama.jamanetwork.com

(en) Isakova T, Xie H, Yang W. et al. « Fibroblast growth factor 23 and risks of mortality and end‐stage renal disease in patients with chronic kidney disease » JAMA 2011;305:2432-9. PMID 21673295

jci.org

(en) Faul C, Amaral AP, Oskouei B. et al. « FGF23 induces left ventricular hypertrophy » J Clin Invest. 2011;121:4393-408. PMID 21985788

nature.com

(en) Larsson T, Nisbeth U, Ljunggren O, Juppner H, Jonsson KB. « Circulating concentration of FGF‐23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers » Kidney Int. 2003;64:2272-9. PMID 14633152

nejm.org

Carpenter TO, Whyte MP, Imel EA et al. Burosumab therapy in children with X-linked hypophosphatemia, N Engl J Med, 2018;378:1987-1998
(en) Gutierrez OM, Mannstadt M, Isakova T. et al. « Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis » N Engl J Med. 2008;359:584-92. PMID 18687639

nih.gov

ncbi.nlm.nih.gov

« Publications PubMed pour l'Homme », sur National Center for Biotechnology Information, U.S. National Library of Medicine
« Publications PubMed pour la Souris », sur National Center for Biotechnology Information, U.S. National Library of Medicine
(en) Shimada T, Hasegawa H, Yamazaki Y. et al. « FGF‐23 is a potent regulator of vitamin D metabolism and phosphate homeostasis » J Bone Miner Res. 2004;19:429-35. PMID 15040831
(en) Larsson T, Nisbeth U, Ljunggren O, Juppner H, Jonsson KB. « Circulating concentration of FGF‐23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers » Kidney Int. 2003;64:2272-9. PMID 14633152
(en) Gattineni J, Bates C, Twombley K. et al. « FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1 » Am J Physiol Renal Physiol. 2009;297:F282–F291. PMID 19515808
(en) Faul C, Amaral AP, Oskouei B. et al. « FGF23 induces left ventricular hypertrophy » J Clin Invest. 2011;121:4393-408. PMID 21985788
(en) Touchberry CD, Green TM, Tchikrizov V. et al. FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy Am J Physiol Endocrinol Metab. 2013;304:E863. PMID 23443925
(en) Agarwal I, Ide N, Ix JH. et al. « Fibroblast Growth Factor–23 and cardiac structure and function » J Am Heart Assoc. 2014;3:e000584. PMID 24525546
(en) Imel EA, Econs MJ. « Fibroblast growth factor 23: roles in health and disease » J Am Soc Nephrol. 2005;16:2565–75. PMID 16033853
(en) Liu S, Quarles LD. « How fibroblast growth factor 23 works » J Am Soc Nephrol. 2007;18:1637–47. PMID 17494882
(en) Gutierrez OM, Januzzi JL, Isakova T. et al. « Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease » Circulation 2009;119:2545-52. PMID 19414634
(en) Mirza MA, Larsson A, Melhus H, Lind L, Larsson TE. « Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population » Atherosclerosis 2009;207:546-51. PMID 19524924
(en) Gutierrez OM, Mannstadt M, Isakova T. et al. « Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis » N Engl J Med. 2008;359:584-92. PMID 18687639
(en) Isakova T, Xie H, Yang W. et al. « Fibroblast growth factor 23 and risks of mortality and end‐stage renal disease in patients with chronic kidney disease » JAMA 2011;305:2432-9. PMID 21673295
(en) Parker BD, Schurgers LJ, Brandenburg VM. et al. « The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study » Ann Intern Med. 2010;152:640-8. PMID 20479029
(en) Seiler S, Cremers B, Rebling NM. et al. « The phosphatonin fibroblast growth factor 23 links calcium‐phosphate metabolism with left‐ventricular dysfunction and atrial fibrillation » Eur Heart J. 2011;32:2688-96. PMID 21733911

oxfordjournals.org

eurheartj.oxfordjournals.org

(en) Seiler S, Cremers B, Rebling NM. et al. « The phosphatonin fibroblast growth factor 23 links calcium‐phosphate metabolism with left‐ventricular dysfunction and atrial fibrillation » Eur Heart J. 2011;32:2688-96. PMID 21733911

physiology.org

ajprenal.physiology.org

(en) Gattineni J, Bates C, Twombley K. et al. « FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1 » Am J Physiol Renal Physiol. 2009;297:F282–F291. PMID 19515808

ajpendo.physiology.org

(en) Touchberry CD, Green TM, Tchikrizov V. et al. FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy Am J Physiol Endocrinol Metab. 2013;304:E863. PMID 23443925

sciencedirect.com

(en) Mirza MA, Larsson A, Melhus H, Lind L, Larsson TE. « Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population » Atherosclerosis 2009;207:546-51. PMID 19524924

wiley.com

onlinelibrary.wiley.com

(en) Shimada T, Hasegawa H, Yamazaki Y. et al. « FGF‐23 is a potent regulator of vitamin D metabolism and phosphate homeostasis » J Bone Miner Res. 2004;19:429-35. PMID 15040831